Cancer

NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum

SANTA ANA, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage…

3 months ago

Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder

Tonix anticipates filing the IND application in the fourth quarter of 2025 TNX-102 SL is a potential first-in-class treatment for…

3 months ago

Phio Pharmaceuticals to Present at the Life Sciences Future Conference

Key updates to include advances made in the on-going clinical trial for INTASYL siRNA lead product candidate PH-762King of Prussia,…

3 months ago

Precision Cell Systems Completes Two Acquisitions to Consolidate Best-in-Class Technologies Serving 700+ Customers for Cell Analysis

LIVERMORE, Calif., Sept. 17, 2025 /PRNewswire/ -- Today, Precision Cell Systems (PCS) announced its official launch following the strategic acquisitions…

3 months ago

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

BOSTON, Sept. 17, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science…

3 months ago

University Hospitals Collaborates with Vitalchat to Set National Standard in Virtual Nursing

UH Lake West Medical Center go-live makes UH among the first hospital systems in the U.S. to fully implement a…

3 months ago

HealthTree Foundation Enhances and Expands Its AI-Powered Personalized Clinical Trial Finder

The HealthTree Clinical Trial Finder Now Matches All Blood Cancer Patients to Eligible Clinical Trials Based on Their Medical Records…

3 months ago

NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy

LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The world’s first therapeutic drug to be equipped with NovalGen’s pioneering AutoRegulation (AR)…

3 months ago

Propanc Biopharma Receives Certificate of Grant for “Proenzyme Composition” Patent from US Patent & Trademark Office

Fourth US Granted Patent Captures Claims for Future Clinical Dose of PRPMELBOURNE, Australia, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Propanc…

3 months ago

Akari Therapeutics Announces Filing for New Patent for Novel ADC Platform Utilizing Spliceosome Payload PH1 for the Treatment of Cancer

BOSTON and LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel…

3 months ago